CLINICAL STUDY
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
Robert J. Scheubel, MD* ,*,
Mike Tostlebe, MS,
Andreas Simm, PhD*,
Susanne Rohrbach, MD,
Roland Prondzinsky, MD ,
Frank N. Gellerich, PhD ,
Rolf-Edgar Silber, MD* and
Juergen Holtz, MD
* Cardio-Thoracic Surgery, Halle/Saale, Germany
Cardiology, Halle/Saale, Germany
Neurology , Halle/Saale, Germany
Institute of Pathophysiology, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany
Manuscript received May 7, 2002;
revised manuscript received July 24, 2002,
accepted August 11, 2002.
* Reprint requests and correspondence: Dr. Robert J. Scheubel, Klinik für Herz- und Thoraxchirurgie, Martin-Luther-Universitaet Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Halle (Saale), Germany.
robert.scheubel{at}medizin.uni-halle.de
OBJECTIVES: Activity of mitochondrial respiratory chain complexes with and without mitochondrially encoded subunits was assessed in failing human myocardium together with parameters of mitochondrial gene expression.
BACKGROUND: Mutations and deletions in mitochondrial genome (mtDNA) sporadically accumulate in the aging myocardium. In experimental heart failure, they are discussed to be a generalized problem resulting in disturbances of mitochondrial gene expression and mitochondrial function.
METHODS: In left ventricular specimens from 43 explanted failing hearts and 10 donor hearts, enzyme activities of respiratory chain complexes, messenger ribonucleic acid (mRNA) expression of mitochondrially and nuclear encoded mitochondrial components (reverse transcriptase-polymerase chain reaction, Northern blot), undeleted wildtype mtDNA (Southern blot), and nuclear encoded mitochondrial transcription factor A (mtTFA) (Western blot) were quantified.
RESULTS: Citrate synthase normalized activity of mitochondrial respiratory chain complex I, which contains seven mitochondrially encoded subunits, was decreased by 28% in terminally failing myocardium, whereas the activity of the exclusively nuclear encoded complex II was unchanged. However, the amount of intact mtDNA, the mRNA of all mitochondrially encoded subunits of the entire respiratory chain, the amount of mtTFA, and the enzymatic activity of complex III and complex IV, which also contain mitochondrially encoded subunits, were normal compared with donor hearts, excluding generalized disturbance of mitochondrial gene expression. Retrospective analysis of drug therapy before transplantation identified beta-blockers as one putative protection against this disturbance.
CONCLUSIONS: In terminally failing human myocardium of patients receiving drug therapy, complex I depression is not caused by mtDNA damage and disturbed mitochondrial gene expression. The absence of mtDNA damage should facilitate recovery of the overloaded myocardium, if effective unloading could be achieved.
|
Abbreviations and Acronyms
| | ACE | | angiotensin-converting enzyme | | CAD | | coronary artery disease | | COX | | cytochrome oxidase | | DCM | | dilated cardiomyopathy | | mRNA | | messenger ribonucleic acid | | mtDNA | | mitochondrial deoxyribonucleic acid | | mtRNA | | mitochondrial ribonucleic acid | | mtTFA | | mitochondrial transcription factor A | | NADH | | nicotinamide adenine dinucleotide | | NO | | nitric oxide | | PCR | | polymerase chain reaction | | RNA | | ribonucleic acid | | rRNA | | ribosomal ribonucleic acid | | RT-PCR | | reverse transcriptase-polymerase chain reaction | | TNF | | tumor necrosis factor |
|
This article has been cited by other articles:
|
|
|
|
 
J. S. Ingwall
On the Control of Metabolic Remodeling in Mitochondria of the Failing Heart
Circ Heart Fail,
July 1, 2009;
2(4):
275 - 277.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Garnier, J. Zoll, D. Fortin, B. N'Guessan, F. Lefebvre, B. Geny, B. Mettauer, V. Veksler, and R. Ventura-Clapier
Control by Circulating Factors of Mitochondrial Function and Transcription Cascade in Heart Failure: A Role for Endothelin-1 and Angiotensin II
Circ Heart Fail,
July 1, 2009;
2(4):
342 - 350.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.G. Nekolla, S. Reder, A. Saraste, T. Higuchi, G. Dzewas, A. Preissel, M. Huisman, T. Poethko, T. Schuster, M. Yu, et al.
Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model
Circulation,
May 5, 2009;
119(17):
2333 - 2342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. van Bilsen, F. A. van Nieuwenhoven, and G. J. van der Vusse
Metabolic remodelling of the failing heart: beneficial or detrimental?
Cardiovasc Res,
February 15, 2009;
81(3):
420 - 428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Rosca, E. J. Vazquez, J. Kerner, W. Parland, M. P. Chandler, W. Stanley, H. N. Sabbah, and C. L. Hoppel
Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation
Cardiovasc Res,
October 1, 2008;
80(1):
30 - 39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Wall, J. Wei, M. Ly, P. Belmont, J. J. Martindale, D. Tran, J. Sun, W. J. Chen, W. Yu, P. Oeller, et al.
Alterations in oxidative phosphorylation complex proteins in the hearts of transgenic mice that overexpress the p38 MAP kinase activator, MAP kinase kinase 6
Am J Physiol Heart Circ Physiol,
November 1, 2006;
291(5):
H2462 - H2472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk
Myocardial Substrate Metabolism in the Normal and Failing Heart
Physiol Rev,
July 1, 2005;
85(3):
1093 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Di Lisa and P. Bernardi
Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition
Cardiovasc Res,
May 1, 2005;
66(2):
222 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Moe, J. Marin-Garcia, A. Konig, M. Goldenthal, X. Lu, and Q. Feng
In vivo TNF-{alpha} inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure
Am J Physiol Heart Circ Physiol,
October 1, 2004;
287(4):
H1813 - H1820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ventura-Clapier, A. Garnier, and V. Veksler
Energy metabolism in heart failure
J. Physiol.,
February 15, 2004;
555(1):
1 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. van Bilsen, P. J.H Smeets, A. J Gilde, and G. J van der Vusse
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
Cardiovasc Res,
February 1, 2004;
61(2):
218 - 226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Fosslien
Mitochondrial Medicine - Cardiomyopathy Caused by Defective Oxidative Phosphorylation
Ann. Clin. Lab. Sci.,
October 1, 2003;
33(4):
371 - 395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Garnier, D Fortin, C Delomenie, I Momken, V Veksler, and R Ventura-Clapier
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
J. Physiol.,
September 1, 2003;
551(2):
491 - 501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Scheubel
Reply
J. Am. Coll. Cardiol.,
June 18, 2003;
41(12):
2299 - 2299.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Marin-Garcia
Mitochondrial dysfunction in heart failure
J. Am. Coll. Cardiol.,
June 18, 2003;
41(12):
2299 - 2299.
[Full Text]
[PDF]
|
|
|
|
